Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12

Raphael Lis, Cyril Touboul, Pejman Mirshahi, Fadoua Ali, Sharon Mathew, Daniel J. Nolan, Mahtab Maleki, Salma A. Abdalla, Christophe M. Raynaud, Denis Querleu, Eman Al-Azwani, Joel Malek, Massoud Mirshahi, Arash Rafii Tabrizi

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Hyperthermic intraperitoneal chemotherapy (HIPEC) has shown promise in treatment of ovarian carcinosis. Despite its efficiency for the treatment of peritoneal carcinosis from digestive tract neoplasia, it has failed to demonstrate significant benefit in ovarian cancers. It is therefore essential to understand the mechanism underlying resistance to HIPEC in ovarian cancers. Mesenchymal stem cells (MSC) play an important role in the development of ovarian cancer metastasis and resistance to treatments. A recent study suggests that MSCs may be cytotoxic for cancer cells upon heat shock. In contrast, we describe the protective role of MSC against hyperthermia. Using cytokine arrays we determined that the tumor associated MSC (TAMC) secrete pro-tumoral cytokines. We studied the effect of hyperthermia in co-culture setting of TAMC or BM-MCS associated with ovarian cancer cell lines (SKOV3 and CaOV3) with polyvariate flow cytometry. We demonstrate that hyperthermia does not challenge survival of TAMC or bone marrow derived MSC (BM-MSC). Both TAMC and BM-MSC displayed strong protective effect inducing thermotolerance in ovarian cancer cells (OCC). Transwell experiments demonstrated the role of secreted factors. We showed that CXCL12 was inducing thermotolerance and that inhibition of CXCL12/CXCR4 interaction restored cytotoxicity of hyperthermia in co-culture experiments. Contrary to the previous published study we demonstrated that TAMC and BM-MSC co-cultured with OCC induced thermotolerance in a CXCL12 dependant manner. Targeting the interaction between stromal and cancer cells through CXCL12 inhibition might restore hyperthermia sensitivity in ovarian cancers, and thus improve HIPEC efficiency.

Original languageEnglish
Pages (from-to)715-725
Number of pages11
JournalInternational Journal of Cancer
Volume128
Issue number3
DOIs
Publication statusPublished - 1 Feb 2011

Fingerprint

Mesenchymal Stromal Cells
Ovarian Neoplasms
Fever
Neoplasms
Bone Marrow
Coculture Techniques
Drug Therapy
Cytokines
Stromal Cells
Gastrointestinal Tract
Shock
Flow Cytometry
Therapeutics
Hot Temperature
Neoplasm Metastasis
Cell Line
Thermotolerance

Keywords

  • CXCL12
  • hyperthermia
  • mesenchymal stem cells
  • ovarian cancer resistance

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12. / Lis, Raphael; Touboul, Cyril; Mirshahi, Pejman; Ali, Fadoua; Mathew, Sharon; Nolan, Daniel J.; Maleki, Mahtab; Abdalla, Salma A.; Raynaud, Christophe M.; Querleu, Denis; Al-Azwani, Eman; Malek, Joel; Mirshahi, Massoud; Tabrizi, Arash Rafii.

In: International Journal of Cancer, Vol. 128, No. 3, 01.02.2011, p. 715-725.

Research output: Contribution to journalArticle

Lis, R, Touboul, C, Mirshahi, P, Ali, F, Mathew, S, Nolan, DJ, Maleki, M, Abdalla, SA, Raynaud, CM, Querleu, D, Al-Azwani, E, Malek, J, Mirshahi, M & Tabrizi, AR 2011, 'Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12', International Journal of Cancer, vol. 128, no. 3, pp. 715-725. https://doi.org/10.1002/ijc.25619
Lis, Raphael ; Touboul, Cyril ; Mirshahi, Pejman ; Ali, Fadoua ; Mathew, Sharon ; Nolan, Daniel J. ; Maleki, Mahtab ; Abdalla, Salma A. ; Raynaud, Christophe M. ; Querleu, Denis ; Al-Azwani, Eman ; Malek, Joel ; Mirshahi, Massoud ; Tabrizi, Arash Rafii. / Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12. In: International Journal of Cancer. 2011 ; Vol. 128, No. 3. pp. 715-725.
@article{e3083b7ce5b941b09c5a657a9176692e,
title = "Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12",
abstract = "Hyperthermic intraperitoneal chemotherapy (HIPEC) has shown promise in treatment of ovarian carcinosis. Despite its efficiency for the treatment of peritoneal carcinosis from digestive tract neoplasia, it has failed to demonstrate significant benefit in ovarian cancers. It is therefore essential to understand the mechanism underlying resistance to HIPEC in ovarian cancers. Mesenchymal stem cells (MSC) play an important role in the development of ovarian cancer metastasis and resistance to treatments. A recent study suggests that MSCs may be cytotoxic for cancer cells upon heat shock. In contrast, we describe the protective role of MSC against hyperthermia. Using cytokine arrays we determined that the tumor associated MSC (TAMC) secrete pro-tumoral cytokines. We studied the effect of hyperthermia in co-culture setting of TAMC or BM-MCS associated with ovarian cancer cell lines (SKOV3 and CaOV3) with polyvariate flow cytometry. We demonstrate that hyperthermia does not challenge survival of TAMC or bone marrow derived MSC (BM-MSC). Both TAMC and BM-MSC displayed strong protective effect inducing thermotolerance in ovarian cancer cells (OCC). Transwell experiments demonstrated the role of secreted factors. We showed that CXCL12 was inducing thermotolerance and that inhibition of CXCL12/CXCR4 interaction restored cytotoxicity of hyperthermia in co-culture experiments. Contrary to the previous published study we demonstrated that TAMC and BM-MSC co-cultured with OCC induced thermotolerance in a CXCL12 dependant manner. Targeting the interaction between stromal and cancer cells through CXCL12 inhibition might restore hyperthermia sensitivity in ovarian cancers, and thus improve HIPEC efficiency.",
keywords = "CXCL12, hyperthermia, mesenchymal stem cells, ovarian cancer resistance",
author = "Raphael Lis and Cyril Touboul and Pejman Mirshahi and Fadoua Ali and Sharon Mathew and Nolan, {Daniel J.} and Mahtab Maleki and Abdalla, {Salma A.} and Raynaud, {Christophe M.} and Denis Querleu and Eman Al-Azwani and Joel Malek and Massoud Mirshahi and Tabrizi, {Arash Rafii}",
year = "2011",
month = "2",
day = "1",
doi = "10.1002/ijc.25619",
language = "English",
volume = "128",
pages = "715--725",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12

AU - Lis, Raphael

AU - Touboul, Cyril

AU - Mirshahi, Pejman

AU - Ali, Fadoua

AU - Mathew, Sharon

AU - Nolan, Daniel J.

AU - Maleki, Mahtab

AU - Abdalla, Salma A.

AU - Raynaud, Christophe M.

AU - Querleu, Denis

AU - Al-Azwani, Eman

AU - Malek, Joel

AU - Mirshahi, Massoud

AU - Tabrizi, Arash Rafii

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Hyperthermic intraperitoneal chemotherapy (HIPEC) has shown promise in treatment of ovarian carcinosis. Despite its efficiency for the treatment of peritoneal carcinosis from digestive tract neoplasia, it has failed to demonstrate significant benefit in ovarian cancers. It is therefore essential to understand the mechanism underlying resistance to HIPEC in ovarian cancers. Mesenchymal stem cells (MSC) play an important role in the development of ovarian cancer metastasis and resistance to treatments. A recent study suggests that MSCs may be cytotoxic for cancer cells upon heat shock. In contrast, we describe the protective role of MSC against hyperthermia. Using cytokine arrays we determined that the tumor associated MSC (TAMC) secrete pro-tumoral cytokines. We studied the effect of hyperthermia in co-culture setting of TAMC or BM-MCS associated with ovarian cancer cell lines (SKOV3 and CaOV3) with polyvariate flow cytometry. We demonstrate that hyperthermia does not challenge survival of TAMC or bone marrow derived MSC (BM-MSC). Both TAMC and BM-MSC displayed strong protective effect inducing thermotolerance in ovarian cancer cells (OCC). Transwell experiments demonstrated the role of secreted factors. We showed that CXCL12 was inducing thermotolerance and that inhibition of CXCL12/CXCR4 interaction restored cytotoxicity of hyperthermia in co-culture experiments. Contrary to the previous published study we demonstrated that TAMC and BM-MSC co-cultured with OCC induced thermotolerance in a CXCL12 dependant manner. Targeting the interaction between stromal and cancer cells through CXCL12 inhibition might restore hyperthermia sensitivity in ovarian cancers, and thus improve HIPEC efficiency.

AB - Hyperthermic intraperitoneal chemotherapy (HIPEC) has shown promise in treatment of ovarian carcinosis. Despite its efficiency for the treatment of peritoneal carcinosis from digestive tract neoplasia, it has failed to demonstrate significant benefit in ovarian cancers. It is therefore essential to understand the mechanism underlying resistance to HIPEC in ovarian cancers. Mesenchymal stem cells (MSC) play an important role in the development of ovarian cancer metastasis and resistance to treatments. A recent study suggests that MSCs may be cytotoxic for cancer cells upon heat shock. In contrast, we describe the protective role of MSC against hyperthermia. Using cytokine arrays we determined that the tumor associated MSC (TAMC) secrete pro-tumoral cytokines. We studied the effect of hyperthermia in co-culture setting of TAMC or BM-MCS associated with ovarian cancer cell lines (SKOV3 and CaOV3) with polyvariate flow cytometry. We demonstrate that hyperthermia does not challenge survival of TAMC or bone marrow derived MSC (BM-MSC). Both TAMC and BM-MSC displayed strong protective effect inducing thermotolerance in ovarian cancer cells (OCC). Transwell experiments demonstrated the role of secreted factors. We showed that CXCL12 was inducing thermotolerance and that inhibition of CXCL12/CXCR4 interaction restored cytotoxicity of hyperthermia in co-culture experiments. Contrary to the previous published study we demonstrated that TAMC and BM-MSC co-cultured with OCC induced thermotolerance in a CXCL12 dependant manner. Targeting the interaction between stromal and cancer cells through CXCL12 inhibition might restore hyperthermia sensitivity in ovarian cancers, and thus improve HIPEC efficiency.

KW - CXCL12

KW - hyperthermia

KW - mesenchymal stem cells

KW - ovarian cancer resistance

UR - http://www.scopus.com/inward/record.url?scp=78649841894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649841894&partnerID=8YFLogxK

U2 - 10.1002/ijc.25619

DO - 10.1002/ijc.25619

M3 - Article

VL - 128

SP - 715

EP - 725

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 3

ER -